nsv4767002
- Organism: Homo sapiens
- Study:nstd199 (Quan et al. 2021)
- Variant Type:inversion
- Method Type:Sequencing
- Submitted on:GRCh37
- Variant Calls:1
- Validation:Not tested
- Clinical Assertions: No
- Region Size:16,166
- Publication(s):Quan et al. 2021
Source: NCBI
- Genome View
- Variant Region Details and Evidence
- Validation Information
- Clinical Assertions
- Genotype Information
Genome View
Select assembly:Overlapping variant regions from other studies: 454 SVs from 37 studies. See in: genome view
Overlapping variant regions from other studies: 451 SVs from 37 studies. See in: genome view
Variant Region Placement Information
| Variant Region ID | Placement Type | Score | Assembly | Assembly Unit | Reciprocity | Sequence ID | Chr | Start | Stop |
|---|---|---|---|---|---|---|---|---|---|
| nsv4767002 | Remapped | Good | GRCh38.p12 | Primary Assembly | First Pass | NC_000023.11 | ChrX | 101,598,810 | 101,614,975 |
| nsv4767002 | Submitted genomic | GRCh37 (hg19) | Primary Assembly | NC_000023.10 | ChrX | 100,853,788 | 100,869,965 |
Variant Call Information
| Variant Call ID | Type | Method | Analysis |
|---|---|---|---|
| nssv16276193 | inversion | Sequencing | Split read mapping |
Variant Call Placement Information
| Variant Call ID | Placement Type | Score | HGVS | Assembly | Reciprocity | Sequence ID | Chr | Start | Stop |
|---|---|---|---|---|---|---|---|---|---|
| nssv16276193 | Remapped | Good | NC_000023.11:g.101 598810_101614975in v | GRCh38.p12 | First Pass | NC_000023.11 | ChrX | 101,598,810 | 101,614,975 |
| nssv16276193 | Submitted genomic | NC_000023.10:g.100 853788_100869965in v | GRCh37 (hg19) | NC_000023.10 | ChrX | 100,853,788 | 100,869,965 |